Direct Oral Anticoagulants for Atrial Fibrillation: Does Size Matter?

JACC Clin Electrophysiol. 2021 May;7(5):659-661. doi: 10.1016/j.jacep.2021.03.008.

Authors

Anthony L Lin¹, Gregory M Marcus²

Affiliations

¹ Department of Medicine, University of California-San Francisco, San Francisco, California, USA.
² Department of Medicine, University of California-San Francisco, San Francisco, California, USA; Electrophysiology Section, Division of Cardiology, Department of Medicine, University of California-San Francisco, San Francisco, California, USA. Electronic address: greg.marcus@ucsf.edu.

PMID: 34016392
DOI: 10.1016/j.jacep.2021.03.008

No abstract available

Keywords: DOAC; atrial fibrillation; stroke; warfarin.

Publication types

Editorial
Comment

MeSH terms

Anticoagulants / adverse effects
Atrial Fibrillation* / complications
Atrial Fibrillation* / drug therapy
Body Mass Index
Humans
Warfarin

Substances

Anticoagulants
Warfarin